Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Irish start-up Merrion Pharmaceuticals nets €5.6mm in IEE IPO

Executive Summary

Merrion Pharmaceuticals (oral drug delivery) netted €5.6mm in its initial public offering of 2mm shares at €4.05 each--below its €4.21-4.91 range announced in October--on the Irish Stock Exchange's Irish Enterprise Exchange. The company had planned to sell a total of 4mm shares including ADSs for $6-7 per share on Nasdaq, but withdrew the US offering due to market conditions.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
      • Controlled Release
      • Macromolecule
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies